(Q36770454)

16 August 2017

1 reference

title

Idiosyncratic adverse reactions to antiepileptic drugs (English)

1 reference

16 August 2017

3

Emilio Perucca

1 reference

16 August 2017

Gaetano Zaccara

1

1 reference

PubMed ID

17386054

16 August 2017

Diego Franciotta

series ordinal

2

1 reference

16 August 2017

26 March 2007

1 reference

16 August 2017

1 reference

16 August 2017

48

1 reference

16 August 2017

1223-1244

1 reference

16 August 2017

7

1 reference

Children versus adults: pharmacokinetic and adverse-effect differences

16 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

HLA-B locus in Caucasian patients with carbamazepine hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Reversible parkinsonism and cognitive impairment with chronic valproate use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Life-threatening adverse events of antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Valproate-associated pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Safety and efficacy of divalproex sodium monotherapy in partial epilepsy: a double-blind, concentration-response design clinical trial. Depakote Monotherapy for Partial Seizures Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Progress report on new antiepileptic drugs: a summary of the Eigth Eilat Conference (EILAT VIII)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Aplastic anemia induced by phenytoin: a geriatric case with severe folic acid deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Effect of L-carnitine treatment for valproate-induced hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Valproic acid hepatic fatalities. III. U.S. experience since 1986.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

The H1 histamine receptor regulates allergic lung responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Monitoring for adverse effects of antiepileptic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Asymptomatic children with epilepsy: little benefit from screening for anticonvulsant-induced liver, blood, or renal damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Lamotrigine-associated anticonvulsant hypersensitivity syndrome in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Toxic epidermal necrolysis with combination lamotrigine and valproate in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Clinicopathological and genotypic aspects of anticonvulsant-induced pseudolymphoma syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Medical genetics: a marker for Stevens-Johnson syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Toxic epidermal necrolysis: current evidence, practical management and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Surveillance for fatal suspected adverse drug reactions in the UK

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Mechanism of topiramate-induced acute-onset myopia and angle closure glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Thrombocytopenia during valproic acid treatment in young patients with new-onset bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Methods of evaluating immunotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

l-Carnitine Supplementation in Childhood Epilepsy: Current Perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Role of glutathione S-transferases A1-1, M1-1, and P1-1 in the detoxification of 2-phenylpropenal, a reactive felbamate metabolite.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

The chemistry, toxicology, and identification in rat and human urine of 4-hydroxy-5-phenyl-1,3-oxazaperhydroin-2-one: a reactive metabolite in felbamate bioactivation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Valproic acid hepatic fatalities: a retrospective review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Valproic acid hepatic fatalities. II. US experience since 1984.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Adverse drug reactions: definitions, diagnosis, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Prospective evaluation of risk factors of cutaneous drug reactions to sulfonamides in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Eosinophilic hepatitis caused by lamotrigine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Topiramate-associated acute, bilateral, secondary angle-closure glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

The ketogenic diet: from molecular mechanisms to clinical effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Familial occurrence of hypersensitivity to phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Immunoregulation of allergic contact dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Idiosyncratic reactions: new methods of identifying high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Anticonvulsant hypersensitivity syndrome: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Effects of age and polytherapy, risk factors of valproic acid (VPA) hepatotoxicity, on the excretion of thiol conjugates of (E)-2,4-diene VPA in people with epilepsy taking VPA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Acute pancreatitis in children from Valproic acid: case series and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Clinical assessment of drug-induced disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Reversible pseudoatrophy of the brain and mental deterioration associated with valproate treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Effects of new anticonvulsant medications on porphyrin synthesis in cultured liver cells: potential implications for patients with acute porphyria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Risk of aplastic anemia in patients using antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Phenytoin and dyskinesias: a report of two cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Predictors of Lamotrigine-associated rash

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Myoclonus in epilepsy patients with anticonvulsive add-on therapy with pregabalin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Population-based drug-induced agranulocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Phenytoin desensitization in a child with symptomatic localization-related epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Mechanism of idiosyncratic drug reactions: reactive metabolite formation, protein binding and the regulation of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

The development of drug metabolising enzymes and their influence on the susceptibility to adverse drug reactions in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Reactivity of atropaldehyde, a felbamate metabolite in human liver tissue in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Idiosyncratic drug hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Evaluation of case reports of aplastic anemia among patients treated with felbamate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Stevens-Johnson syndrome in patients on phenytoin and cranial radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Idiosyncratic drug reactions: the reactive metabolite syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Severe hepatotoxicity during valproate therapy: an update and report of eight new fatalities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Fatal liver failure associated with valproate therapy in a patient with Friedreich's disease: review of valproate hepatotoxicity in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Current understanding of delayed anticonvulsant hypersensitivity reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Effectiveness of first antiepileptic drug.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

The usefulness of skin tests to prove drug hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

STUDIES ON THE SENSITIZATION OF ANIMALS WITH SIMPLE CHEMICAL COMPOUNDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Genetic polymorphism of cytochrome P450 2C9 in diphenylhydantoin-induced cutaneous adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Lamotrigine-induced tourettism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Experimental and clinical evidence for loss of effect (tolerance) during prolonged treatment with antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Zonisamide and associated oligohidrosis and hyperthermia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Hyperammonemic encephalopathy induced by a combination of valproate and pivmecillinam

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

The TH1/TH2 paradigm in allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Allergic skin reactions to anticonvulsant medications in patients receiving cranial radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Parkinsonism and/or cognitive impairment with valproic acid therapy: a report of ten cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

The danger model: a renewed sense of self

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Valproic acid-induced hyperammonemia: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Acute hepatitis associated with lamotrigine and managed with the molecular adsorbents recirculating system (Mars).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Glucose-6-phosphate dehydrogenase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Safety review of adult clinical trial experience with lamotrigine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Characterization of drug-specific T cells in lamotrigine hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Thrombocytopenia in association with adjunctive felbamate use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Carbamazepine-induced hypersensitivity syndrome, associated with human herpesvirus 6 reactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Felbamate-associated fatal acute hepatic necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Biphasic effects of carbamazepine on the dopaminergic system in rat striatum and hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Fatal progressive hepatic necrosis associated with lamotrigine treatment: a case report and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Letter: Primidone thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Felbamate: consensus of current clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Clinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Harnessing the clinical potential of antiepileptic drug therapy: dosage optimisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Pharmacological and clinical aspects of antiepileptic drug use in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Pharmacological interaction of drugs with antigen-specific immune receptors: the p-i concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Delayed Drug Hypersensitivity Reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Cellular and molecular pathophysiology of cutaneous drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

21 January 2018

Adverse drug reactions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

TNFalpha promoter region gene polymorphisms in carbamazepine-hypersensitive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

The danger hypothesis--potential role in idiosyncratic drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Investigating the role of 2-phenylpropenal in felbamate-induced idiosyncratic drug reactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

In vivo and in vitro testing for adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Interleukin-10-secreting type 1 regulatory T cells in rodents and humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Lymphadenopathy induced by anticonvulsant drugs and mimicking clinically pathologically malignant lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Antiepileptic drug hypersensitivity syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

The danger hypothesis applied to idiosyncratic drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

21 January 2018

Drug hypersensitivity.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Absence of Cross-Reactivity between Sulfonamide Antibiotics and Sulfonamide Nonantibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Carbamazepine-induced acute liver failure as part of the DRESS syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Pure red cell aplasia during carbamazepine monotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Synthesis and in vitro reactivity of 3-carbamoyl-2-phenylpropionaldehyde and 2-phenylpropenal: putative reactive metabolites of felbamate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Identification of modified atropaldehyde mercapturic acids in rat and human urine after felbamate administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Antioxidant enzymes in blood of patients with Friedreich's ataxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

New concepts in immunology relevant to idiosyncratic drug reactions: the "danger hypothesis" and innate immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Carbamazepine-induced systemic lupus erythematosus presenting as cardiac tamponade

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Secondary renal Fanconi syndrome caused by valproate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Possible drug-induced thrombocytopenia secondary to tiagabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Cytokines as a therapeutic target for allergic diseases: a complex picture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Acute changes of blood ammonia may predict short-term adverse effects of valproic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Genetic analysis of microsomal epoxide hydrolase in patients with carbamazepine hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Metabolism of Lamotrigine to a Reactive Arene Oxide Intermediate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Role of Drug Disposition in Drug Hypersensitivity: A Chemical, Molecular, and Clinical Perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

Drug-induced systemic lupus erythematosus after 8 years of treatment with carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01041.X

10.1111/J.1528-1167.2007.01041.X

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference

PubMed ID

17386054